Moderna wins EU tender to supply COVID-19 vaccines for up to four years, offering diverse formats like prefilled syringes to ...

The Agreement provides participating countries with the opportunity to diversify their mRNA COVID-19 vaccine supply and gain access to pre-filled ...

Although the protection against COVID-19 still offers a significant ... their cash runway to at least 16 months, presuming no revenues in 2025. Overall, Moderna's transition from pandemic to ...

Through the first nine months of 2024, Moderna's revenue of $2.3 billion represents ... underscoring the company's continued dependence on its COVID-19 shot, commercialized as Spikevax.

Earlier this month, Moderna convinced investor to send the stock ... Moderna was thriving during Covid-19 pandemic when its mRNA-based Covid-19 vaccine was successfully distributed to cater ...

Moderna (MRNA) announced that it has been awarded a tender for the supply of its mRNA COVID-19 vaccine in the European Union, Norway and North ...

1, for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals six months of age and older. Moderna is a leader in the creation of the field of mRNA medicine. Through the ...